An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)
Conditions: Acute Lymphoblastic Leukemia; Lymphoblastic Leukemia Interventions: Drug: IM JZP-458; Drug: IV JZP-458 Sponsors: Jazz Pharmaceuticals; Children's Oncology Group (COG) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Cancer & Oncology | Children | Leukemia | Lymphoma | Research | Study